TherapeuticsMD
TXMD
TXMD
39 hedge funds and large institutions have $7.61M invested in TherapeuticsMD in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $9.02M → $7.61M (-$1.41M)
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
Holders
39
Holding in Top 10
–
Calls
$92K
Puts
$52K
Top Buyers
| 1 | +$293K | |
| 2 | +$72.8K | |
| 3 | +$24.4K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.25K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.29K |
Top Sellers
| 1 | -$75.5K | |
| 2 | -$47.2K | |
| 3 | -$18.2K | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
-$4.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.11K |